One study analyzed a family with hereditary HHC, and its findings showed that the proband with severe thromboembolic disease who failed to accept folic acid therapy carried a homozygous variant of the MTHFD1 gene, which did not occur in the sons who were sensitive to folic acid therapy [71]. This evidence concerns the gene MTHFD1 and Thromboembolism.